Clinical Trials Browser

Has announcements × Pancreatic Neoplasms × trastuzumab deruxtecan × Clear all

NCT04482309 2026-04-09

DPT02

Phase 2 Active not recruiting

477 enrolled 2 FDA

Gastrointestinal

Pancreatic Neoplasms, Colorectal Neoplasms